0319

Welcome to the March issue of The Ophthalmologist! You’ll find the latest research in Upfront – our news segment – plus opinion pieces from some of ophthalmology’s brightest minds in In My View. This month, Sheraz Daya shares his thoughts on calcified IOLs, while Brian Joondeph considers the Obamacare's future in Trump’s America. In our feature, Europe’s leading retinal surgeons explain how breakthrough gene therapies are changing the way we treat retinal disease. In Practice sees Bhavin Shah ruminate on tomorrow’s myopia pandemic, while Alexandre Pedinielli and Francesca Amoroso – creators of the OD-OS Navilas Retina Laser – talk about the art of invention in our NextGen section. We also take a moment to reflect on the life-changing legacy of Amos Twinamasiko in Profession, before we Sit Down With Paulo Stanga, lead vitreoretinal surgeon at the London Vision Clinic. Enjoy!

Articles featured in this issue

Subspecialties Imaging & Diagnostics

Image of the Month

03/12/2019 | Aleksandra Jones

March's Image of the Month by Terry Tarrant

Subspecialties Business and Innovation

Genetic Versus Economic

03/05/2019 | Aleksandra Jones

Our newfound ability to harness the power of gene therapy is facing an age-old challenge: financial constraints

Subspecialties Basic & Translational Research

Changing the Channel

02/28/2019 | Phoebe Harkin

A quest to tackle LCA emphasizes the essence of precision medicine

Subspecialties Cornea / Ocular Surface

Ahead of the Curve

03/20/2019 | Phoebe Harkin

The science behind “self-curving” corneas

Subspecialties Basic & Translational Research

Bitesize Breakthroughs

02/20/2019 | Phoebe Harkin

The latest ophthalmology news – in brief

Subspecialties Cataract

Can We Fix It? Yes, We Can!

02/28/2019 | Sheraz Daya

When a patient comes to us with a calcified IOL, all is not lost. The solution is clear, but it requires care and skill

Subspecialties Retina

Rewarding Work

03/07/2019 | James Bainbridge

Tomorrow’s cures for retinopathies will likely include advanced gene and cell therapies delivered by precision surgery

Subspecialties Basic & Translational Research

Big Ideas

03/08/2019 | Robert MacLaren

Gene therapies are no longer just hype – they provide tangible benefits to real patients, today

Subspecialties Retina

The Test of Time

03/05/2019 | Michel Michaelides

Reflecting on the past – and future – of gene therapy

Subspecialties Retina

(Not) Going Viral

03/05/2019 | Mariya Moosajee

Plasmid vectors are gaining traction as a viable alternative in gene therapy delivery

Subspecialties Glaucoma

The Import of Space and Time

03/08/2019 | Sponsored by Haag-Streit Diagnostics

During glaucoma progression, subtle changes can be masked by background fluctuations – and, therefore, entirely missed by standard monitoring methods.